Review paper

Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations

Volume: 37, Issue: 8, Pages: 747 - 759
Published: May 17, 2020
Abstract
Background Pediatric anxiety disorders such as generalized anxiety disorder (GAD) are common, impairing, and often undertreated. Moreover, many youth do not respond to standard, evidence-based psychosocial or psychopharmacologic treatment. An increased understanding of the gamma-aminobutyric acid (GABA) and glutamate neurotransmitter systems has created opportunities for novel intervention development for pediatric GAD. Methods This narrative...
Paper Details
Title
Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations
Published Date
May 17, 2020
Volume
37
Issue
8
Pages
747 - 759
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.